NASDAQ:SYRE News 2 January 2026

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

Spyre Therapeutics shares fell 2.7% to $29.75 Monday as biotech stocks underperformed, with the SPDR S&P Biotech ETF down 1.7% and the S&P 500 ETF up 0.7%. Investors are watching for 2026 clinical trial updates and the company’s late-February quarterly report.

5 January 2026

NASDAQ:SYRE·Stock Market

Spyre Therapeutics stock slid 6.6% into the weekend — here’s what matters before Monday’s open

Spyre Therapeutics (SYRE) fell 6.6% to $30.58 Friday, trading between $30.11 and $32.89 on about 889,000 shares. The company expects key Phase 2 trial data in ulcerative colitis and rheumatic diseases in 2026. Shares ticked up 2% after hours. Investors are watching for macroeconomic data and sector news as markets reopen Monday.

4 January 2026

NASDAQ:SYRE·Stock Market

Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

Spyre Therapeutics shares dropped about 7% to $30.48 in Friday afternoon trading, underperforming biotech ETFs, which slipped less than 1%. The decline follows a recent peak and comes as investors await 2026 clinical trial data and the company’s next quarterly update in late February.

2 January 2026

Biotechnology·NASDAQ:SYRE·Stock Market

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026

U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.

Cloud computing stocks rebounded — but Amazon’s $200 billion spending plan keeps traders on edge

7 February 2026

Cloud-focused ETFs rose Friday, with the First Trust Cloud Computing ETF up 4.4% and WisdomTree’s fund up 3.5%. Amazon fell 5.6% after projecting $200 billion in 2026 capex, while Microsoft gained 1.8% and Alphabet slipped 2.5%. Investors weighed AI’s impact on software growth. Key cloud earnings and delayed U.S. jobs data are due next week.

Big Tech stocks swing on AI spending fears: Amazon slides, Nvidia rebounds as week ahead looms

7 February 2026

Amazon shares fell 5.6% Friday after projecting $200 billion in 2026 capital spending, while Nvidia jumped 7.9%. The Dow closed above 50,000 for the first time, but the Nasdaq is down 0.9% for the year. Microsoft and Alphabet also signaled major AI investments, sending software stocks down sharply. Chipmakers rallied as Nvidia reported surging AI chip demand.

Data Center Stocks Surge Into the Weekend: Digital Realty, Equinix and Vertiv Set Up a Big Week Ahead

7 February 2026

Digital Realty, Equinix, and Vertiv shares surged Friday, with Vertiv up 10% and Digital Realty rising 4.1%, as investors rotated back into AI-linked data center stocks. The move followed Amazon’s $200 billion and Alphabet’s $175–185 billion 2026 capex targets. Digital Realty set 2026 core FFO guidance at $7.90 to $8.00 per share. Wall Street ended the week broadly higher, led by chipmakers.

NASDAQ:SYRE News 2 January 2026 - 5 January 2026

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

Spyre Therapeutics stock slid 6.6% into the weekend — here’s what matters before Monday’s open

Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

Stock Market Today

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Cloud computing stocks rebounded — but Amazon’s $200 billion spending plan keeps traders on edge

Big Tech stocks swing on AI spending fears: Amazon slides, Nvidia rebounds as week ahead looms

Data Center Stocks Surge Into the Weekend: Digital Realty, Equinix and Vertiv Set Up a Big Week Ahead